Abstract: The invention relates to cheese and cheese-like products comprising about 0.2 to about 6% by weight ?s-casein, ?-casein, or a combination thereof, at least about 5% by weight of one or more hydrocolloids comprising one or more starches, and wherein the cheese or cheese-like product has one or more characteristics of a dairy product, such as flavour, taste, aroma, body, appearance, texture, firmness, handling, density, structure, coagulation, binding, leavening, aeration, foaming, emulsification, elasticity, viscoelasticity, melt, creaminess and mouthfeel.

Abstract: A water treatment system is disclosed. The water treatment system comprises a filtration module comprising one or more ultrafiltration membrane configured to remove one or more non-PFAS contaminant from a PFAS contaminated water stream to provide a partially purified water stream containing soluble PFAS contaminants. The water treatment system also comprises a sorption module comprising one or more sorption units comprising a sorbent material, the sorption module being in fluid communication with the filtration module and downstream therefrom and configured to remove substantially all PFAS contaminants from the partially purified water stream to provide purified water that is substantially free from PFAS contamination.

Abstract: The invention relates to LAG-3 binding agents, in particular variable heavy chain (VH) sdAbs and bispecific agents that target both LAG-3 and PD-1, and the use of such binding agents in the treatment, prevention and detection of disease.

Abstract: The invention relates to PD-1 binding agents that do not block the interaction of PD-1 with its ligands, and the use of such binding agents in the treatment, prevention and detection of disease.

Abstract: The invention relates to PD-1 binding agents that block the interaction of PD-1 with its ligands, and the use of such binding agents in the treatment, prevention and detection of disease.

Abstract: The invention relates to PD-1 binding agents that block the interaction of PD-1 with its ligands, and the use of such binding agents in the treatment, prevention and detection of disease.

Abstract: The invention relates to multifunctional PD-1 binding agents and the use of such binding agents in the treatment, prevention and detection of disease.

Abstract: The disclosure relates to multispecific agents that simultaneously bind CD137 and PD-1 and which comprise a single domain antibody specific to CD137 and a moiety that binds PD-1, for example a single domain antibody. The disclosure also relates to therapeutic and diagnostic applications of such agents, for example in the treatment of a cancer.

Abstract: The invention relates to multifunctional PD-1 binding agents and the use of such binding agents in the treatment, prevention and detection of disease.

Abstract: A water treatment system is disclosed. The water treatment system comprises a filtration module comprising one or more ultrafiltration membrane configured to remove one or more non-PFAS contaminant from a PFAS contaminated water stream to provide a partially purified water stream containing soluble PFAS contaminants. The water treatment system also comprises a sorption module comprising one or more sorption units comprising a sorbent material, the sorption module being in fluid communication with the filtration module and downstream therefrom and configured to remove substantially all PFAS contaminants from the partially purified water stream to provide purified water that is substantially free from PFAS contamination.

Abstract: The invention relates to LAG-3 binding agents, in particular particularly variable heavy chain (VH) sdAbs and bispecific agents that target both LAG-3 and PD-1, and the use of such binding agents in the treatment, prevention and detection of disease.

Abstract: The disclosure relates to agents that simultaneously bind CD137 and PSMA and which comprise a single domain antibody specific to CD137 and a moiety that binds PSMA. The disclosure also relates to therapeutic and diagnostic applications of such agents, for example in the treatment or detection of a cancer.

Abstract: The disclosure relates to CD137 binding agents and the use of such binding agents in the treatment, prevention and detection of disease.

Abstract: The invention relates to PD-1 binding agents that block the interaction of PD-1 with its ligands, and the use of such binding agents in the treatment, prevention and detection of disease.

Abstract: The invention relates to PD-1 binding agents that do not block the interaction of PD-1 with its ligands, and the use of such binding agents in the treatment, prevention and detection of disease.

Abstract: The invention relates to multifunctional PD-1 binding agents and the use of such binding agents in the treatment, prevention and detection of disease.

Abstract: A method and apparatus are provided for presenting a reminder for a PIM record when there may be an opportunity for personal interaction regarding the PIM record. The opportunity for personal interaction regarding the PIM record may be identified in response to a trigger condition not associated with the PIM record. In one embodiment, an opportunity for interaction regarding a PIM record may be identified using identification information associated with the trigger condition. In another embodiment, an opportunity for interaction regarding a first PIM record may be identified when there is a contact associated with the first PIM record and a second PIM record, and there is an occurrence of a trigger condition associated with a second PIM record. In some embodiments, the portable electronic device may utilize additional information to identify or verify opportunities for interaction regarding a PIM record.

Abstract: A system and method provide bidirectional context-based text disambiguation. In one implementation, a processor receives an input text comprising a set of string objects, which may include ambiguous objects such as incomplete or unrecognizable words of a selected language. The processor identifies a set of candidate word objects corresponding to at least a first one of the string objects and a second one of the string objects. Each candidate word object represents, for example, a complete or recognizable word of the selected language. The processor outputs a selected word object in place of a first one of the string objects, as a function of a contextual comparison between one or more candidate word objects corresponding to the first string object and one or more candidate word objects corresponding to the second string object.

Abstract: A method of facilitating input at an electronic device includes detecting a first touch at a first touch location on a touch-sensitive device; the first touch being associated with a first character; detecting a second touch at a second touch location on the touch-sensitive surface, the second touch being associated with a second character; when movement of one of the first touch and the second touch is detected, determining a distance between the first touch location and the second touch location, the distance being associated with a number of characters of an object; identifying candidate objects in reference data that match the number of characters and include an initial character that matches the first character and a final character that matches the second character; and displaying at least one candidate object.

Abstract: A method of controlling an electronic device, including a touch-sensitive display, includes detecting a gesture associated with a gesture character entry mode and determining a direction of the gesture on the touch-sensitive display, determining ones of a plurality of characters associated with the gesture based on the direction, and adding the ones of the plurality of characters to candidate character strings.